Targeted transfection of the IL-3 gene into primary human hematopoietic progenitor cells through the c-kit receptor

Experimental Hematology

Volumn 27, Issue 2, 1999, Pages 250-258

  Chapel, Alain ^a   Poncet, Pascal ^b   Neildez Nguyen, Thi My Anh ^a   Vétillard, Jérome ^a   Brouard, Nathalie ^a   Goupy, Christophe ^c   Chavanel, Gisèle ^c   Hirsch, François ^c   Thierry, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b INSTITUT PASTEUR   (France)

^c CNRS   (France)

Author keywords

Antifection; C kit Receptor; CD117; Hematopoietic progenitor; IL 3; Inert vector; Transfection

Indexed keywords

CD34 ANTIGEN; DNA; RECOMBINANT INTERLEUKIN 3; RNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; STEM CELL;

ANTIGENS, CD34; GENE TARGETING; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0033036366     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00009-5     Document Type: Article

References (28)

1. Moen R.C. Direction in gene therapy. Blood Cells. 17:1991;407.
2. May G., Enver T. Targeting gene expression to hematopoietic stem cells. a chromatin-dependent upstream element mediates cell type-specific expression of the stem cell antigen CD34 EMBO J. 14:1995;564.
3. Michael S.I., Curiel D.T. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther. 1:1994;223.
4. Etienne-Julan M., Roux P., Carillo S., Jeanteur P., Piechaczyck M. The efficiency of cell targeting by recombinant retroviruses depend on the nature of the receptor and the composition of the artificial cell-virus linker. J Gen Virol. 73:1992;3251.
5. Neda H., Wu C.H., Wu G.Y. Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. J Biol Chem. 266:1991;14143.
6. Kasahara N., Dozy A.M., Kan Y.W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science. 266:1994;1373.
7. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem. 262:1987;4429.
8. Zenck M., Steinlein P., Wagner E., Cotten M., Beug H., Birnstiel M. Receptor-mediated endocytosis of specific transferrin-polycation conjugates an efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci USA. 87:1990;3655.
9. Buschle M., Cotten M., Kirlappos H., Mechtler K., Schnaffner G., Zauner W., Birnstiel M.L., Wagner E. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor conjugate. Hum Gene Ther. 6:1995;753.
10. Schwarzenberger P., Spence E., Gooya J.M., Michiel D., Curiel D.T., Ruscetti F.W., Keller J.R. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood. 87:1996;472.
11. Hirsch F., Poncet P., Freeman S., Gress R.E., Sachs D.H., Druet P., Hirsch R. Antifection. a new method for targeted gene transfection Transplant Proc. 25:1993;138.
12. Poncet P., Panczak A., Goupy C., Gustafsson K., Blanpied C., Chavanel G., Hirsch R., Hirsch F. Antifection. an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivo Gene Ther. 3:1996;731.
13. Wagemaker G., Neelis K.J., Wognum A.W. Surface markers and growth factors receptors of immature hematopoietic cell subsets. Stem Cells. 13:1995;165.
14. Sato N., Caux C., Kitamura T., Watanabe Y., Arai K.-I., Banchereau J., Miyajima A. Expression and factor-dependent modulation of interleukin-3 receptor subunits on human hematopoietic cells. Blood. 82:1993;752.
15. Berenson R.J., Bensinger W.I., Kalamasz D. Positive selection of viable cell populations using avidin-biotin immunoadsorption. J Immunol Meth. 91:1986;11.
16. Issaad C., Croisille L., Katz A., Vainchenker W., Coulombel L. A murine stroma cell line allows the proliferation of very primitive human CD34+/CD38- progenitor cells in long-term cultures and semisolid assays. Blood. 81:1993;2916.
17. Yates J.L., Warreb N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 313:1985;812.
18. Oosterwijk E., Ruiter D.J., Hoedemaeker P.J., Pauwels E.K., Jonas U., Zwartendijk J., Warnaar S.O. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer. 38:1986;489.
19. Fauser A., Messner H. Granuloerythropoietic colonies in human marrow, peripheral blood and cord blood. Blood. 52:1978;1243.
20. Chomczynski P.A. Reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques. 15:1993;532.
21. Sharf J.S., Horn G.T., Erlich H.A. Direct cloning analysis of enzymatically amplified genomic sequences. Science. 233:1986;1076.
22. Cunningham M. Spot blot. a hybridization assay for specific DNA sequences in multiples samples Ann Biochem. 128:1982;415.
23. Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Pia Y.-F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin. J Cell Physiol. 140:1989;323.
24. Kitamura T., Tojo A., Kuwaki T., Chiba S., Miyazono K., Urabe A., Takaku F. Identification of human erythropoietin receptors on a factor dependent cell line TF-1. Blood. 73:1989;375.
25. Kitamura T., Takaku F., Miyajima A. IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hematopoietic cell line, TF-1. Int Immunol. 3:1991;571.
26. Brizzi M.F., Blechman J.M., Cavalloni G., Yarden Y., Pegoraro L. Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells. Oncogene. 9:1994;1583.
27. Alai M., Mui A.L., Cutler R.L., Bustelo X.R., Barbacid M., Krystal G. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hematopoietic cells. J Biol Chem. 267:1992;18021.
28. Orkin S.H., Motulsky A.G. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. NIH. December 7:1995.